MANASSAS, Va. —Jeeva Clinical Trials announced the acquisition of Clintelligence AI, an AI-powered protocol intelligence platform designed to improve trial planning, accelerate patient recruitment, and reduce clinical development risk. The acquisition expands Jeeva’s growing AI-ready clinical research infrastructure and strengthens its position as a next-generation platform for decentralized and hybrid clinical trials.
The integration of Clintelligence AI will allow Jeeva to bring pre-trial intelligence directly into its unified ecosystem, helping sponsors and research organizations identify operational risks earlier, optimize protocol design, and improve study feasibility before trials begin.
According to Jeeva Founder and CEO, Dr. Harsha K. Rajasimha, the future of clinical research depends on moving beyond fragmented systems and building infrastructure designed specifically for AI-enabled workflows. The acquisition aligns with Jeeva’s broader strategy to modernize clinical trial operations through connected, AI-driven systems that improve collaboration, efficiency, and patient outcomes.
The move comes amid accelerating investment and consolidation across the AI-driven clinical research and drug development landscape, as organizations look to reduce timelines, improve enrollment outcomes, and streamline increasingly complex studies. Industry analysts and researchers continue to highlight AI’s growing role in trial simulation, protocol optimization, and predictive modeling throughout the clinical development lifecycle.
Jeeva’s platform currently supports decentralized and hybrid clinical trials through an integrated operating system designed to connect sponsors, CROs, research sites, and patients through a unified workflow environment. The company recently introduced a refreshed brand identity and expanded its AI-focused clinical operations strategy, emphasizing scalable infrastructure for future AI-assisted clinical research.
The acquisition of Clintelligence AI further positions Jeeva as part of a growing wave of companies reshaping clinical development through intelligent automation, predictive analytics, and connected digital trial ecosystems.
About Jeeva Clinical Trials
Jeeva Clinical Trials is the developer of the industry’s first Unified AI-Ready Digital Infrastructure for clinical research. Its platform delivers complete, end-to-end clinical trial execution, including AI-guided protocol design and writing, patient screening/recruitment and eConsent, electronic data capture (EDC), interactive web response system (IWRS), electronic patient reported outcomes (ePRO) and electronic clinical outcomes assessments (eCOA), centralized scheduling and trial management (CTMS), eVisits, and centralized monitoring, under a single login, data model, and workflow layer, now enhanced with Agentic AI capabilities and Clinical Data Management services. Trusted by biopharma sponsors, CROs, and academic medical centers worldwide, Jeeva is available on AWS Marketplace. For more information, visit www.jeevatrials.com.
